At the cellular level, butyrate possesses antioxidant effects that reduce oxidative stress and prevent ferroptosis
In conclusion, as we witness the evolving landscape of obesity management, GLP-1 agonists stand tall as potent allies in fostering weight loss and promoting holistic well-being
In a Phase 2a trial for the treatment of non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo
Key Reasons for the Ban: Lack of scientific and therapeutic rationale for combination use No added clinical benefit over individual drug therapy Increased risk of adverse drug reactions and drug interactions Potential contribution to antimicrobial resistance (in antibiotic combinations) Overall unnecessary burden on patients and healthcare systems Regulatory Action: The ban reflects Indias strengthened approach toward evidence-based medicine and rational drug use, ensuring that only safe, effective, and clinically justified drug combinations remain in the market
IV (intravenous) therapy delivers fluids and selected nutrients directly into the bloodstream, which is why many travelers choose a short "beauty break" partway through their trip
P., He, Y., Meng, C
